LFG
ANIP icon

Larson Financial Group’s ANI Pharmaceuticals ANIP Stock Holding History

Larson Financial Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.5K Buy
228
+77
+51% +$6.01K ﹤0.01% 1919
2025
Q4 		$11.9K Buy
+151
New +$13.1K ﹤0.01% 2017
2025
Q3 		– Sell
-2
Closed -$131 – 3437
2025
Q2 		$131 Buy
+2
New +$130 ﹤0.01% 3130

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Larson Financial Group's ANIP Position: Q1 2026 in Review

Larson Financial Group increased its ANI Pharmaceuticals (ANIP) stake by 51% in Q1 2026, buying an estimated $6.01K and bringing the position to 228 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1919.

Larson Financial Group first reported a position in ANIP in Q2 2025 and has held it in 3 quarters since. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Larson Financial Group held 228 shares of ANI Pharmaceuticals worth $17.5K as of Q1 2026.
  • Larson Financial Group bought 77 ANI Pharmaceuticals shares in Q1 2026, an estimated $6.01K.
  • ANI Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1919 holding.
  • Larson Financial Group first reported a position in ANI Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.